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A B S T R A C T
There is growing understanding that the environment plays an important role both in the transmission of an-
tibiotic resistant pathogens and in their evolution. Accordingly, researchers and stakeholders world-wide seek to
further explore the mechanisms and drivers involved, quantify risks and identify suitable interventions. There is
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a clear value in establishing research needs and coordinating efforts within and across nations in order to best
tackle this global challenge. At an international workshop in late September 2017, scientists from 14 countries
with expertise on the environmental dimensions of antibiotic resistance gathered to define critical knowledge
gaps. Four key areas were identified where research is urgently needed: 1) the relative contributions of different
sources of antibiotics and antibiotic resistant bacteria into the environment; 2) the role of the environment, and
particularly anthropogenic inputs, in the evolution of resistance; 3) the overall human and animal health impacts
caused by exposure to environmental resistant bacteria; and 4) the efficacy and feasibility of different techno-
logical, social, economic and behavioral interventions to mitigate environmental antibiotic resistance.1
1. Introduction
Addressing the global challenge of antibiotic resistance requires a
“one-health perspective” that takes into account the connections be-
tween human and animal health and the environment2 (Robinson et al.,
2016). This approach is needed because bacteria and bacterial genes
often have the ability to move between all three compartments, in any
direction (Forsberg et al., 2012; Martinez, 2018; Woolhouse et al.,
2015). Such a strategy has been adopted not only within the Global
Action Plan of the WHO (WHO, 2015), but also in regional action plans
(EC, 2017), in many national action plans (e.g. (India, 2017; Sweden,
2016), by the pharmaceutical industry (IFPMA, 2016) and in the work
of other organizations (Access-to-Medicine-Foundation, 2018; AMR-
review, 2016). The role of the environment as a transmission route for
many bacterial pathogens has long been recognized, often associated
with insufficient sewage infrastructure, fecal contamination of water or
organic fertilizers (Allen et al., 2010; Bengtsson-Palme et al., 2018a;
Finley et al., 2013; Huijbers et al., 2015; Levin et al., 2014; Pruden
et al., 2013). More recently, the understanding has developed that
many of the resistance genes that we find in pathogens today originate
from bacteria normally thriving in the environment (D'Costa et al.,
2011; Forsberg et al., 2012; Poirel et al., 2008; Potron et al., 2011;
Taylor et al., 2011; Wellington et al., 2013). Hence, the environment
acts as a dispersal route and reservoir of resistant pathogens, and also as
an arena for the evolution of resistance (Fig. 1; Bengtsson-Palme et al.
2018b). This paper identifies key knowledge gaps associated with both
of these biological processes (transmission and evolution) and with
mitigation of associated risks. Improving science related to the en-
vironmental dimension is critical in order to efficiently curb further
development and spread of antibiotic resistance in pathogens
(Berendonk et al., 2015; Finley et al., 2013; Gaze et al., 2013; Topp
et al., 2018).
The Joint Programming Initiative on Antimicrobial Resistance
(JPIAMR) brings together different disciplines for collaboration on
antimicrobial resistance research, harmonizes joint actions (including
coordination of international research calls) and strives to reduce re-
search overlap (www.jpiamr.eu). It currently involves 27 countries,
mainly from Europe, but also from other regions of the world (e.g.
Canada, India, Japan, and South Africa). The JPIAMR is organized
around six priority topics, of which the Environment is one. A Strategic
Research Agenda (JPIAMR, 2014) was developed in 2014, providing
guidance to much of the activities. The present paper is the result of an
initiative by the JPIAMR to receive expert advice on critical knowledge
gaps to be considered in an upcoming revision of the Strategic Research
Agenda, likely in 2018, and to identify possible areas for dedicated
future research calls. However, we recognize that the value of defining
such knowledge gaps extends far beyond influencing this particular, but
important, policy document.
2. Structure of the workshop
A workshop was organized in Gothenburg, Sweden on the 27–28th
of September 2017 by the JPIAMR, the Swedish Research Council (SRC)
and the Centre for Antibiotic Resistance research at University of
Gothenburg (CARe). The workshop was led by Professor Joakim
Larsson with Professors Ana-Maria de Roda Husman and Ramanan
Laxminarayan as additional breakout group leaders. Participants were
either invited directly by the SCR or recommended by the individual
member states (the majority of participants), whereas some partici-
pated in their roles in the different parts of the JPIAMR (e.g. manage-
ment board, steering committee, scientific advisory board), the
European Commission or the European Joint Action on Antimicrobial
Resistance and Healthcare Associated Infections (JAMRAI). Prior to the
workshop, a questionnaire, open to input from anyone, was launched
via the websites of JPIAMR and CARe in Gothenburg, Sweden (www.
care.gu.se), and was also announced in a dedicated presentation at the
4th International Symposium on the Environmental Dimension of
Antibiotic Resistance held in Michigan, USA, in August 2017 (http://
www.antibiotic-resistance.de). The workshop was organized into three
breakout groups, each given the task to deal with knowledge gaps re-
lated to evolution, transmission or interventions. The reports of the
breakout groups were then discussed among all participants to clarify
and structure the areas where more research is needed. The discussions
were used to describe four overarching critical knowledge gaps, and
hence corresponding research needs. The core focus was on antibiotic
resistance in bacteria.
3. Critical knowledge gaps
The workshop participants identified that the environmental
priority topic section in the current Strategic Research Agenda should
be revised to better reflect the current state of knowledge of the role of
the environment in antibiotic resistance development. In particular, it
should embrace the need to evaluate and develop social interventions
(not just technical solutions), have a stronger emphasis of the need to
understand the role of anthropogenic inputs of selective agents on
evolutionary processes in the environment leading to resistance, and
stress the need for quantitative risk assessment of the impacts of ex-
posure via environmental routes on human and animal health. These
and additional knowledge gaps were structured into four overarching
gaps described below.
1. What are the relative contributions of different sources of antibiotics
and antibiotic resistant bacteria into the environment?
Although the complete picture is still unclear, there is a growing
body of knowledge on the mass flows of both selective agents and re-
sistant bacteria that reach the environment from different sources and
through distinct pathways (Aubertheau et al., 2017; Bueno et al., 2017;
Kummerer, 2009; SCENIHR, 2009; Wolters et al., 2016). Better quan-
tification of the contribution from such sources, routes of propagation
and exposure paths would help populate quantitative transmission and
risk models and rank risks (Ashbolt et al., 2013; Pruden et al., 2013;
Schijven et al., 2011). The selection pressure imposed on environmental
1 The recommendations from the workshop have also been communicated in a separate
report published on the website of the JPIAMR (www.jpiamr.org).
2 There is no complete consensus on how to interpret “environment” in this context,
but here we refer to environments outside the bodies of humans and domestic animals,
excluding the clinical, in-door environment.
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bacteria is determined by the type of selective agent, their concentra-
tions, their chemical speciation, co-exposure to many selective agents,
the time of exposure, and to what degree the environmental conditions
are permissive for bacterial growth (Baquero et al., 2009). Uncertainties
in each of these aspects prevent understanding of where and to what
extent selective agents promote resistance in the environment. Health
risks also depend on the probability that resistant bacteria in the en-
vironment reach humans and domestic animals, covered below.
To better assess the significance of different sources of antibiotics
and antibiotic resistant bacteria into the environment, knowledge of the
abundance, characteristics and natural variability of resistance genes
and mobile genetic elements, as well as their mobilization/transfer
frequencies in different types of environments is needed (Hunter et al.,
2008; McLain et al., 2016; Mirkin et al., 2003; Pal et al., 2016;
Ravenhall et al., 2015; Rothrock et al., 2016; Zhu et al., 2017). Such
data are also helpful when evaluating effects of interventions and in-
tervention experiments (see below). It is important to understand that
many events in microbial communities are stochastic and vary over
time, resulting in quantification challenges (Nielsen et al., 2014;
Pettersen et al., 2005). Standardized surveillance methods (for selective
agents, bacteria, mobile genetic elements and resistance genes in ma-
trices such as manure, wastewater and surface water) and reporting
formats would be valuable in this context (Berendonk et al., 2015;
Matheu et al., 2017). Surveillance of resistance in fecal bacteria in e.g.
untreated sewage could potentially also serve as an indicator (or early
warning) of the levels of regional clinical resistance and how they
change over time (Alleweldt et al., 2017; Kwak et al., 2015).
2. What is the role of the environment as affected by anthropogenic
inputs (e.g. pollution and other activities) on the evolution (mobi-
lization, selection, transfer, persistence etc.) of antibiotic resistance?
The relationship between antibiotic exposure and selection for re-
sistance in bacterial communities is poorly understood (Aminov, 2009;
Bengtsson-Palme et al. 2018b; Bengtsson-Palme and Larsson, 2016;
Gullberg et al., 2011; Le Page et al., 2017; Lundstrom et al., 2016).
Similar gaps also exist for non-antibiotic, co-selective compounds (e.g.
metals, biocides), with additional challenges involving the extent of
their co-selective ability and the mechanisms involved (Ostman et al.,
2017; Pal et al., 2017; Wales and Davies, 2015). Understanding of ex-
posure-effect relationships is further complicated by the time needed
for some effects to materialize (Nielsen et al., 2014) and the potential
for mixture effects (Gullberg et al., 2014; Menz et al., 2017; Weinstein
and Zaman, 2017). In addition, the selective potential inevitably varies
substantially between different species and chemical combinations.
Little is also known about the complex interactions between micro-
organisms in communities. For example, antibiotics and other selective
agents could potentially modulate these interactions, both directly
through effects on e.g. quorum sensing (Koul et al., 2016) or indirectly
through the selecting for strains with intrinsic or acquired resistance
(Baquero et al., 1998; Widder et al., 2016). Adequate methods and
research that address selection, evolution, gene transfer and persistence
in complex microbial communities are therefore urgently needed
(Hiltunen et al., 2017; Jechalke et al., 2013; Klumper et al., 2017;
Spencer et al., 2016). Selective agents may also, under some circum-
stances, play a role in facilitating environmental dissemination of
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Fig. 1. Overview of the environmental processes influencing the development and spread of antibiotic resistance and how they relate to the knowledge gaps
presented in this article. Silhouettes represent common sources of antibiotics and resistance genes to the environment. The human silhouette on the left also
represents the human microbiome as a recipient of resistance genes and resistant bacteria from the environment. Arrows correspond to the first three broad categories
of knowledge gaps, while the dashed lines show possible points of intervention (related to the fourth, broad knowledge gap). The illustration is adapted from
Bengtsson-Palme et al. (2018a), FEMS Microbiol. Rev. doi: https://doi.org/10.1093/femsre/fux05, distributed under the CC-BY-NC license.
(https://creativecommons.org/licenses/by-nc/4.0/).
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already resistant pathogens or the antibiotic resistance genes that they
carry. To better understand risks, more attention should be paid to
conditions that favor growth of resistant bacteria, as well as conditions
that permit close interactions between diverse environmental bacteria
and those able to colonize humans (Baquero et al., 2009). Antibiotics
and other antimicrobials may have additional ecological impacts, such
as impairing ecosystem function and services as a result of community
changes, and are thus of concern for other reasons in addition to their
more obvious role in promoting selection for resistance (Ashbolt et al.,
2013; Brandt et al., 2015).
Bacteria do not respect national borders and resistant pathogens are
often quickly disseminated around the world via travelers and the
transport of goods and food (Bengtsson-Palme et al., 2015; De Valliere,
2017; Ruppe et al., 2018). Attempts to identify high risk environments
for the evolution and emergence of resistance as priority targets for
mitigation, should therefore not be geographically restricted but rather
take on a global perspective. Quantitative modelling of evolutionary
processes would clearly be valuable to understand risks for the emer-
gence of resistance in different environments (Manaia, 2017; Martinez
et al., 2015; Nielsen et al., 2014; Pettersen et al., 2005). However, we
recognize that it is non-trivial to populate such models with adequate,
relevant input data, such as the rate at which genes are mobilized, how
often horizontal gene transfer events occur and the concentrations of
antibiotics that drive resistance selection. Largely, this is because such
quantitative data are mostly lacking at present (Hunter et al., 2008;
Jutkina et al., 2017; Jutkina et al., 2016; Scornec et al., 2017).
A retrospective approach, aiming at understanding how the re-
sistance determinants that are clinically problematic today ended up in
pathogens could also be valuable (Davies and Davies, 2010; Forsberg
et al., 2012; Ghaly et al., 2017; Jacoby et al., 2011; Poirel et al., 2008;
Potron et al., 2011; Razavi et al., 2017). This will help to further elu-
cidate the molecular mechanisms involved in mobilization and transfer,
the organisms involved in the process, and the environmental arenas for
transmission; and ultimately aid in estimating the risks for emergence
of new forms of resistance in pathogens. Understanding the different
barriers (genetic as well as ecological) that limit movement of re-
sistance genes from harmless environmental bacteria to pathogens
would help stratify/rank risk environments and direct mitigation stra-
tegies (Bengtsson-Palme et al. 2018b; Martinez, 2011; Porse et al.,
2018; Waglechner and Wright, 2017). To move from identification and
somewhat subjective relative ranking of risks factors to accurately
quantifying risks for the emergence of novel forms of resistance in pa-
thogens is probably very difficult, as these events are likely rare. Es-
tablishing quantitative predictions of the emergence of transferable
resistance is far less tractable than estimating the more quantifiable
risks for transmission of already resistant bacteria to humans (Gaze
et al., 2013; Gaze et al., 2008; Huijbers et al., 2015; Pruden et al., 2013;
Pruden et al., 2006; Wellington et al., 2013).
There are several technical limitations when studying environ-
mental resistomes (Bengtsson-Palme et al., 2017). For example vast
amounts of sequence data are needed to effectively allow the study of
rare antibiotic resistance genes when using exploratory shotgun meta-
genomics. Also, challenges in cultivating many environmental bacteria
limit our ability to identify the hosts carrying resistance factors, as well
as their evolution. Such limitations may be overcome to some degree
using technologies such as qPCR, ResCap, iChip or epicPCR (Lanza
et al., 2018; Nichols et al., 2010; Spencer et al., 2016). Still, techno-
logical limitations constrain our understanding of the nature of en-
vironmental resistomes and their potential to be horizontally trans-
ferred between bacteria (Bengtsson-Palme et al. 2018b; Delmont et al.,
2015). Development of methods with improved sensitivity to identify
rare resistance determinants, establish their genetic context without the
need for cultivation, and improved ability to culture a broader range of
species could expand our opportunities to understand risks.
3. How significant is the exposure of humans to antibiotic resistant
bacteria via different environmental routes, and what is the impact
on human health?
The magnitude of the health impacts, direct as well as indirect,
resulting from environmental exposure to antibiotic resistant bacteria
are unclear (Wuijts et al., 2017). Quantitative data on environmental
exposure are essential in order to attribute an increased disease burden
relative to other exposure routes, such as food consumption and com-
munity or nosocomial transmission (Franz et al., 2014; Huijbers et al.,
2015; Leonard et al., 2015). Further complicating the risk assessment
for environmental transmission is that an initial, rare, introduction of
resistance from the environment in the longer term could have major,
global consequence for health, despite that the quantitative environ-
mental exposure is exceedingly small. On the other hand, much more
common transfers from the environment of resistant bacteria and genes
that are already circulating in the human population and transmitted
via other routes, may only contribute marginally to the overall health
effects (Bengtsson-Palme and Larsson, 2015; Bengtsson-Palme et al.,
2018b). Without knowledge of the impacts, health based targets (WHO,
2010) and derived short-term goals will be difficult to set, and even
more challenging to prioritize. Information on how bacteria, genes and
selective agents reach the environment, as well as knowledge on the
evolution and other processes occurring in the environment, does not,
on its own, provide sufficient evidence to deduce how important dif-
ferent environmental transmission routes are for human health out-
comes. Quantitative human exposure assessments are also needed to
comprehensively assess risks for human health (de Roda Husman and
Larsson, 2016). Although challenging, risks for transmission through
complex routes may be assessed in a quantitative manner. There is a
growing focus on relating environmental exposure to colonization of
humans and animals (Dorado-Garcia et al., 2018; Leonard et al., 2018),
but less so to disease. Much more research will be necessary to quan-
titatively attribute antibiotic resistance to specific transmission routes
in different settings and regions. Furthermore, most studies of antibiotic
resistance in the environment measures point prevalence, are de-
scriptive, and limited in time and scale. Such nonsystematic “snap-
shots” are not sufficient to build the overarching theoretical framework
of resistance dynamics that is needed to further develop hypothesis-
driven research (Bengtsson-Palme et al. 2018b; Nielsen et al., 2014;
Pettersen et al., 2005; Townsend et al., 2012). Some of several chal-
lenges here is to predict the relevant risk scenarios including recipient
bacterial species and resistance traits and to provide relevant input
numbers, e.g., transmission rates, exposure levels or infectious doses, to
such models.
Similar or identical genes and bacteria are often encountered in
both the environment and the human/animal microbiota. This indicates
a flow between environments, but it does not necessarily ascribe the
direction of transmission (Chamosa et al., 2017; Davies and Davies,
2010; Forsberg et al., 2012; Jacoby et al., 2011; Poirel et al., 2008;
Potron et al., 2011). A better understanding of the directionality behind
such transfers of genes and bacteria would help us identify what the
most critical exposure and risk scenarios are. Expanded sampling plans
spanning diverse geographical regions and integrating different en-
vironmental compartments, time points and selection pressures would
contribute to understanding gene flows. Partially, this could be
achieved by better sharing of data, but increased high resolution typing
efforts and sensitive source tracking tools could also be part of such an
approach (Berendonk et al., 2015; Harwood et al., 2014).
4. What technological, social, economic and behavioral interventions
are effective to mitigate the emergence and spread of antibiotic
resistance via the environment?
As there may be great difficulties in evaluating an intervention all
the way to an impact on human health with respect to reduced mor-
bidity, mortality and social costs (Ashbolt et al., 2013), surrogate
D.G.J. Larsson et al. Environment International 117 (2018) 132–138
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endpoints will have to play important roles. Surrogate endpoints can,
for example, include the abundances of resistant bacteria or con-
centrations of selective agents in various environmental matrices.
Currently there are essentially no standards regulating discharges of
antibiotics from production facilities or other sources (Bengtsson-Palme
et al., 2018a, 2018b) although a few antibiotics are included in the
“watch-list” of the European Water Framework Directive (Carvalho
et al., 2015). Development of acceptable emission levels and environ-
mental quality standards for selective agents and resistant bacteria, as
well as methodology to define such levels and standards, would be
useful for several types of interventions, including the management of
industrial discharges (Bengtsson-Palme et al., 2018a; Bengtsson-Palme
and Larsson, 2018; Le Page et al., 2017; Schijven et al., 2011).
To some extent there are already practices and interventions in
place that reduce risks for spreading antibiotic resistant bacteria and
selective agents to the environment, or that reduce the risk for trans-
mission back to humans and animals. Critical question are how effec-
tive those interventions are, and whether current intervention are suf-
ficient, should be further adapted or even replaced/amended by
different interventions. It is already clear that there is a need for cost-
and energy-efficient technological solutions, including formal defini-
tions of Best Available Technologies (BAT), for waste management, also
with respect to AMR (Berendonk et al., 2015). However, the im-
plementation of BAT may need to be prioritized where risks to human
and environmental health are apparent and will have the greatest im-
pact. The most pressing needs for technological interventions are found
in low- and middle-income regions, where waste treatment is often
lacking or of limited efficacy. In this respect, recently developed water
safety plans and sanitation safety plans will play significant roles
(WHO, 2009, 2016). However, there are also initiatives to improve
waste management in high income settings, including removing micro-
contaminants, such as pharmaceuticals, from wastewaters or sludge
(Barbosa et al., 2016; Homem and Santos, 2011; Michael-Kordatou
et al., 2017). Such advanced solutions, including ozonation, activated
carbon, biofilters, and wetland-treatment, should also be evaluated for
their efficiency to reduce concentrations of selective agents and prevent
the spread of resistant bacteria. Although many advanced remediation
solutions may be costly now, these costs should go down over time.
How costs for such solutions can be shared is also an important aspect
to consider.
Critically, interventions are not only of a technical nature, but also
social. Without awareness of the challenges – and what is at stake –
among those able to address them, problems will remain. Strategies
therefore need to be developed and evaluated for each type of key
stakeholder. These include the health-, water- and agricultural sectors,
regulatory agencies, pharma companies, trade associations, NGOs,
media, WHO, FAO, OIE, EU, governments, etc., but also consumers and
patients (Laxminarayan et al., 2016; Laxminarayan et al., 2013).
Making different stakeholders aware of their own ability to make a
difference is a critical step, as well as adapting the message with the
specific receiver in mind. Some stakeholders and regions have a con-
siderably higher awareness than others. An analysis matching lack of
awareness with ability to influence would therefore probably be valu-
able for directing communication initiatives. However, even with
awareness and available technological solutions, there may often be
counter-incentives, typically economic, that prevent effective actions.
Research is therefore needed to both reduce counter-incentives and
create new economic and legal incentives to reduce pollution. Putting a
price tag on carrying on with “business as usual”, could also motivate
actions (Littmann et al., 2015; Van Boeckel et al., 2017). Highlighting
the accumulated economic burden of non-action is an approach where
lessons might be learned from the climate challenge, where such ap-
proaches have been successful in spurring political action.
Identifying interventions (existing and new) and evaluating their
potential efficacy is critical, but their feasibility in different contexts
(geographical, social, economic, political) needs to be considered and
their benefits must be balanced against their associated costs. Negative
consequences of an intervention may be of economic, climate or social
nature, or a combination of all. Importantly, costs and benefits will not
be equally shared among stakeholders and over time, posing added
ethical dilemmas (Anomaly, 2017; Dar et al., 2016; Degeling et al.,
2018; Rogers Van Katwyk et al., 2016; Singer et al., 2016; Wilton et al.,
2002). From a cost-benefit perspective, it is not clear whether measures
primarily protecting the environment from exposure to selective agents,
resistant bacteria and genes, or measures that protect humans from
resistant bacteria and resistance determinants of environmental origin
would be most efficient. It is furthermore not known if it is most ben-
eficial to focus on one's own country or region, or certain regions of the
world, even if distant (Graham et al., 2014). It could also be more ef-
fective to prioritize investments in waste management in certain sec-
tors, such as clinical or pharmaceutical facilities (Andremont and
Walsh, 2015). If so, how would benefits be distributed globally and over
time, and how could costs be shared? Another challenge is how we
should move forward with policy in the face of uncertainty, both with
regards to the basic science, and choice of investments in interventions
that are likely to be effective (Munthe et al., 2018).
4. Conclusions
There are several broad knowledge gaps that need to be filled in
order to more efficiently manage the emergence and spread of anti-
biotic resistance in the environment. Particularly, we have identified
four broad key areas where more research is urgently needed: 1) the
relative contributions of different sources of antibiotics and antibiotic
resistant bacteria into the environment; 2) the role of the environment,
and particularly anthropogenic inputs, on the evolution of resistance; 3)
the overall human and animal health impacts caused by exposure to
resistant bacteria from the environment; and 4) the efficacy of tech-
nological, social, economic and behavioral interventions to mitigate
environmental antibiotic resistance. Addressing all four pillars are ne-
cessary to understand the growing challenges associated with antibiotic
resistance and implement effective strategies for slowing its develop-
ment. We therefore encourage researchers, funding organizations,
policy makers and other relevant stakeholders to take the steps needed
to fill these knowledge gaps.
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